A detailed history of Catalyst Funds Management Pty LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 400 shares of BDX stock, worth $90,256. This represents 0.02% of its overall portfolio holdings.

Number of Shares
400
Holding current value
$90,256
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $88,588 - $96,964
400 New
400 $96.4 Million
Q1 2024

Dec 04, 2024

SELL
$233.45 - $247.73 $23,345 - $24,773
-100 Reduced 25.0%
300 $74.2 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.